
2Seventy Bio (TSVT) Earnings Dates & Reports
2Seventy Bio (TSVT) Most Recent Earnings
Report Date
Period EndingQ1 2025
Est. EPS-$0.10
Actual EPS$0.01
EarningsBeat
2Seventy Bio (TSVT) Earnings
View the latest 2Seventy Bio (TSVT) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in 2Seventy Bio (TSVT)
Order type
Buy in
Order amount
Est. shares
0 shares
2Seventy Bio (TSVT) Earnings per Share (EPS) History
Signup for full accessBrowse free
2Seventy Bio (TSVT) Latest Earnings
The value each TSVT share was expected to gain vs. the value each share gained.
2Seventy Bio (TSVT) reported its most recent earnings on for Q1 2025, posting earnings per share (EPS) of $0.01. This exceeded analysts' expectations of -$0.10 by 110.00%, marking a Beat.
For comparison, 2Seventy Bio reported EPS of -$0.81 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.
2Seventy Bio (TSVT) Earnings History
2Seventy Bio (TSVT) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the 2Seventy Bio’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
2Seventy Bio (TSVT) Earnings FAQs
2Seventy Bio (TSVT) last reported earnings on May 7, 2025 for Q1 2025, posting an EPS of $0.01, which Beat the estimate of -$0.10 by 110.00%.
For Q1 2025, 2Seventy Bio (TSVT) reported an EPS of $0.01, exceeding analysts' estimate of -$0.10 by 110.00%.
For Q1 2025, 2Seventy Bio (TSVT) Beat expectations with an actual EPS of $0.01 vs. an estimated EPS of -$0.10.
Following the last earnings report on May 7, 2025, 2Seventy Bio (TSVT)'s stock price moved — from — to —.
The next 2Seventy Bio (TSVT) earnings call is scheduled for May. 7, 2025, where executives will discuss financial results and outlook.